Malnutrition Exacerbates COVID-19 Outcomes in Hospitalized Liver Cirrhosis Patients
A study published in Cureus has highlighted the significance of addressing the nutritional status of COVID-19 patients with liver cirrhosis, as malnutrition has been found to increase in-hospital mortality rate and other adverse outcomes. Researchers analyzed data from the National Inpatient Sample database and found that among 5,192 liver cirrhosis patients with COVID-19, 11.5% were malnourished. Malnourished patients had a higher prevalence of hyponatremia, chronic kidney disease, and less likely to have hypertension, hyperlipidemia, obesity, and diabetes.
Key Takeaways:
- Malnutrition affects 11.5% of hospitalized liver cirrhosis patients with COVID-19, according to the study.
- Malnourished patients had a significantly higher in-hospital mortality rate (28.5%) compared to non-malnourished patients (18.2%).
- Malnourished patients were more likely to have hyponatremia (36.2% vs. 26.1%) and chronic kidney disease (24.4% vs. 20.2%).
- Malnourished patients were less likely to have hypertension (24.9% vs. 32.3%), hyperlipidemia (23.5% vs. 31.3%), obesity (12.5% vs. 22.0%), and diabetes (8.8% vs. 15.6%).
- The study emphasizes the importance of multidisciplinary management in addressing the nutritional status of COVID-19 patients with liver cirrhosis.
Statistics:
- 5,192 liver cirrhosis patients with COVID-19 were analyzed in the study.
- 599 (11.5%) of the patients were malnourished.
- In-hospital mortality rate among malnourished patients was 28.5%, compared to 18.2% among non-malnourished patients.
- 36.2% of malnourished patients had hyponatremia, compared to 26.1% of non-malnourished patients.
- 24.4% of malnourished patients had chronic kidney disease, compared to 20.2% of non-malnourished patients.
Sources:
- Outcomes of Hospitalized Liver Cirrhosis Patients With COVID-19 Infection: A Retrospective Analysis. Cureus, 2025;17(9).
- Researchers at University of Cincinnati College of Medicine Target COVID-19 (Outcomes of Hospitalized Liver Cirrhosis Patients With COVID-19 Infection: A Retrospective Analysis). Obesity & Diabetes Week. October 20, 2025; p 199.